CLOVER BIO-B 02197·

Gross margin ----------------61.75%--56.16%5.59%78.17%22.01% Net margin -----------------352.92%---2351.51%1998.59%-5851.41%3499.90% ROE ---------493.48%--366.98%860.46%18.90%348.07%55.21%36.31%11.41%43.80% ROA ---------112.55%---52.23%60.32%-6.59%45.63%-111.16%104.57%-44.79%66.37% Revenue growth ---------------------2.13%---90.88%88.75% Attributable profit growth ------------59.25%--94.35%35.10%-552.11%646.46%77.30%629.41% Debt-to-assets --------77.19%--114.23%37.04%134.87%20.64%301.33%166.46%492.50%191.17% Current ratio --------2.36--1.550.810.830.720.350.490.190.16 Operating cash flow / net profit --------0.15--0.690.545.254.560.324.930.950.63 Operating cash flow / revenue -----------------1854.23%---750.89%1103.34%-5558.52%4807.62%

Gross margin 76.34%--100.00%23.66% Net margin -3112.17%--533506.15%536618.31% Revenue growth -----94.50%-- Attributable profit growth ----1043.00%-- Debt-to-assets ----431.30%-- Current ratio ----0.73--

Revenue ----------------39.26M--38.42M2.13%3.50M90.88% Other income and gains 16.91M--24.34M43.96%38.26M57.19%23.25M39.25%2.57B10961.49%97.22M96.22%54.10M44.35% Gross profit ----------------24.24M--21.58M10.99%2.74M87.30% Selling and distribution expenses ----------------54.77M--19.70M64.02%5.07M74.27% Administrative expenses 45.98M------345.71M--410.24M18.67%198.82M51.54%75.17M62.19%66.33M11.76% Net finance costs --------8.22M--5.93M27.82%18.72M215.73%5.76M69.26%377.00K93.45% Operating profit ---------6.01B---2.45B59.29%-119.82M95.10%-897.67M649.21%-204.72M77.19% Profit before tax -48.47M-------6.02B---2.45B59.25%-138.54M94.35%-903.43M552.11%-205.09M77.30% Net profit -48.31M-------6.02B---2.45B59.25%-138.54M94.35%-903.43M552.11%-205.09M77.30% Net profit attributable to owners ---------6.02B---2.45B59.25%-138.54M94.35%-903.43M552.11%-205.09M77.30%

Revenue 3.25M--179.00K94.50% Other income and gains 17.65M--1.11B6200.94% Cost of sales 770.00K--0100.00% Gross profit 2.48M--179.00K92.79% Selling and distribution expenses 4.91M--1.10M77.61% Administrative expenses 29.18M--30.73M5.31% Net finance costs 248.00K--69.00K72.18% Income tax 0--0-- Profit before tax -101.27M--954.98M1043.00% Net profit -101.27M--954.98M1043.00% Net profit attributable to owners -101.27M--954.98M1043.00%

Cash and cash equivalents --------2.77B--1.61B41.92%735.86M54.22%401.24M45.47%267.63M33.30% Trade and bills receivables ----------------24.11M--40.99M70.05%3.00K99.99% Inventories --------768.69M--2.38B210.18%696.98M70.77%11.03M98.42%9.86M10.62% Total current assets --------5.08B--4.39B13.52%1.90B56.73%663.21M65.09%335.83M49.36% Total assets --------5.35B--4.69B12.18%2.10B55.24%812.74M61.32%457.92M43.66% Total current liabilities --------2.15B--2.83B31.71%2.28B19.52%1.91B16.22%1.75B8.23% Total liabilities --------4.13B--5.36B29.96%2.83B47.15%2.45B13.59%2.26B7.91% Equity attributable to owners --------1.22B---668.14M154.80%-732.83M9.68%-1.64B123.28%-1.80B9.84% Total equity --------1.22B---668.14M154.80%-732.83M9.68%-1.64B123.28%-1.80B9.84%

Cash and cash equivalents ----87.30M-- Trade and bills receivables ----1.00K-- Inventories ----4.19M-- Total current assets ----131.19M-- Total assets ----241.84M-- Total current liabilities ----179.38M-- Total liabilities ----1.04B-- Equity attributable to owners -----801.20M-- Total equity -----801.20M--

Net cash from operating activities ---------917.75M---1.69B84.23%-727.88M56.95%-288.49M60.37%-194.83M32.47% Net cash from investing activities --------112.12M---37.51M133.45%-6.16M83.57%3.17M151.42%-12.00K100.38% Net cash from financing activities --------3.06B--483.14M84.20%-142.41M129.48%-51.50M63.84%64.39M225.03% Net change in cash --------2.25B---1.25B155.30%-876.45M29.61%-336.82M61.57%-130.45M61.27%